Treating Corneal Thinning Conditions With CCL Vario Riboflavin (CXL)
Condition:   Keratoconus, Unstable Intervention:   Drug: Riboflavin Sponsor:   Kent Wellish MD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2021 Category: Research Source Type: clinical trials

Safety & Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution
Conditions:   Keratoconus;   Pellucid Marginal Corneal Degeneration;   Corneal Degeneration;   Corneal Ectasia Intervention:   Combination Product: PXL-330 Platinum device for crosslinking with Peschke riboflavin solution Sponsor:   Cornea Associates of Texas Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2020 Category: Research Source Type: clinical trials